A study of more than one million people found the shingles vaccine may lower the risk of heart disease and stroke for up to ...

Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...

Vaccination teams are part of an effort by health authorities across Mexico to contain the country’s biggest measles outbreak ...

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

"Most vaccines are not 100% effective, so you can see vaccine failures, but having vaccine failures doesn't mean the vaccine ...

The shingles vaccine has benefits that stretch beyond protecting older adults from the painful skin condition, a new study ...

People who receive the shingles vaccine have a 23% lower risk of cardiovascular events, such as stroke, and coronary heart ...

The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...

A new study suggests the shingles vaccine may reduce the risk of heart disease for up to eight years post-vaccination. A ...

Researchers found people given a shingles vaccine had a 23% lower risk of cardiovascular events, including stroke, heart ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

When the Department of Health and Human Services (HHS) announced a new requirement for placebo testing on all new vaccines ...